Abstract
Urethritis, with typical symptoms such as dysuria and urethral discharge, is caused by bacteria, fungi, protozoa, and viruses that are often sexually transmitted. Ascending inflammations can lead to sterility and severe clinical pictures. Pathogen characteristics and patient-specific factors determine the course of the disease. If a sexually transmitted infection (STI) is detected, an examination for further STIs should be performed. Gonorrhea affects the mucous membranes of the urogenital and anal tracts, the pharynx, and the conjunctiva. The development of single- and multidrug resistance is a cause for concern. Currently, dual therapy with ceftriaxone and azithromycin is recommended. Urogenital Chlamydia trachomatis infection (Serovars D-K) is one of the most common STIs. In the case of proctitis, LGV infection should be ruled out. Doxycycline or azithromycin are suitable for treatment. Genital Mycoplasma genitalium infections often occur as persistent or recurrent urethritis. Treatment recommendations vary widely because of the increasing development of resistance. Trichomoniasis is considered the STI with the highest prevalence worldwide, but is low in Western European countries. The drug of choice is metronidazole.
References
Internet Pages (Accessed 19.–25.05.2019)
DSTIG-Leitfaden für die Kitteltasche (2014) Available from: http://www.dstig.de/images/DSTIG-Flyer/Leitfaden/sti-leitfaden_version%202.1_web.pdf. Last accessed 23 May 2019
Surveillance atlas of infectious diseases. Available from: http://atlas.ecdc.europa.eu/public/index.aspx. Last accessed 23 May 2019
WHO (2019) Report on global sexually transmitted infection surveillance. Available from: http://apps.who.int/iris/bitstream/10665/249553/1/9789241565301-eng.pdf?ua=1. Last accessed 23 May 2019
Gonorrhea
AWMF (2019) S2k-Leitlinie: Diagnostic and Treatment of Gonorrhea. Available from: https://www.awmf.org/uploads/tx_szleitlinien/059-004l_S2k_Gonorrhoe-Diagnostik-Therapie_2019-03.pdf. Last accessed 25 May 2019
BASHH guidelines Gonorrhea (2019) Available from: https://www.bashhguidelines.org/current-guidelines/urethritis-and-cervicitis/gonorrhoea-2019/. Last accessed 22 May 2019
Beaute J, Cowan S, Hiltunen-Back E et al (2017) Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013. Euro Surveill 22(20). pii: 30537
Belkacem A, Caumes E, Ouanich J, Jarlier V, Dellion S, Cazenave B, Goursaud R, Lacassin F, Breuil J, Patey O (2013) Working Group FRA-DGI. Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011. Sex Transm Infect 89(8):613–5. https://doi.org/10.1136/sextrans-2013-051119
Buder S, Dudareva S, Jansen K, GORENET study group et al (2018) Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infect Dis 18(1):44
Cole MJ, Spiteri G, Jacobsson S, Woodford N, Tripodo F, Amato-Gauci AJ, Unemo M (2017) Euro-GASP ne twork. Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015. BMC Infect Dis 17(1):617. https://doi.org/10.1186/s12879-017-2707-z
Dize L, Agreda P, Quinn N et al (2013) Comparison of self-obtained penile-meatal swabs to urine for the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis. Sex Transm Infect 89(4):305–307
Dudareva-Vizule S, Haar K, Sailer A et al (2014) Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect 90:46–51
Fifer H, Cole M, Hughes G et al (2018) Sustained transmission of high-level azithromycin resistant Neisseria gonorrhoeae in England: an observational study. Lancet Infect Dis 18(5):573–581
Ison CA, Golparian D, Saunders P, Chisholm S, Unemo M (2013) Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcalporA mutants are spreading internationally. Sex Transm Infect 89:197–201. https://doi.org/10.1136/sextrans-2012-050829
https://www.cdc.gov/std/tg2015/gonorrhea.htm. Last accessed 29 Aug 2019
Newman L, Rowley J, Vander Hoorn S et al (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One 10(12):e0143304
Papp JR, Schachter J, Gaydos CA, van der Pol B (2014) Recommendations for the laboratory based detection of Chlamydia trachomatis and Neisseria gonorrhoeae – 2014. MMWR Recomm Rep 63:1–19
Petousis-Harris H, Paynter J, Morgan J et al (2017) Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 390(10102):1603–1610
Serra-Pladevall J, Caballero E, Roig G et al (2015) Comparison between conventional culture and NAATs for the microbiological diagnosis in gonococcal infection. Diagn Microbiol Infect Dis 83:341–343
Tabrizi SN, Unemo M, Golparian D et al (2013) Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol 51:1945–1947
UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/694655/hpr1118_MDRGC.pdf. [last accessed 03 March 2020]
Unemo M (2012) European STI Guidelines Editorial Board. The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill 22:17(47)
Unemo M (2015) Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 15:364
Unemo M, Golparian D, Shafer WM (2014) Challenges with gonorrhea in the era of multidrug and extensively drug resistance – are we on the right track? Expert Rev Anti-Infect Ther 12(6):653–656
Vincent LR, Jerse AE (2018) Biological feasibility and importance of a gonorrhea vaccine for global public health. Vaccine 37(50):7419–7426
Wind CM, de Vries HJ, Schim van der Loeff MF et al (2015) Successful combination of nucleic acid amplification test diagnostics and targeted deferred Neisseria gonorrhoeae culture. J Clin Microbiol 53:1884–1890
Wind CM, Schim van der Loeff MF, Unemo M et al (2016) Test of cure for anogenital gonorrhoea using modern RNA-based and DNA-based nucleic acid amplification tests: a prospective cohort study. Clin Infect Dis 62:1348–1355
Chlamydia Trachomatis
AWMF (2016) S2k-Leitlinie: Infektionen mit Chlamydia trachomatis. Available from: https://www.awmf.org/uploads/tx_szleitlinien/059-005l_S2k_Chlamydia-trachomatis_Infektionen_2016-12.pdf. Last accessed 25 May 2019
Bastidas RJ, Elwell CA, Engel JN, Valdivia RH (2013) Chlamydia intracellular survival strategies. Cold Spring Harb Perspect Med 3:a010256
Cunningham KA, Beagley KW (2008) Male genital tract chlamydial infection: implications for pathology and infertility. Biol Reprod 79(2):180–189
Dudareva-Vizule S, Haar K, Sailer A et al (2016) Chlamydia trachomatis laboratory sentinel team. Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014. Eur Surveill 22(6).:pii:30459
Fode M, Fusco F, Lipshultz L, Weidner W (2016) Sexually transmitted disease and male infertility: a systematic review. Eur Urol Focus 2:383–393
Haar K, Dudareva-Vizule S, Wisplinghoff H et al (2013) Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany. Emerg Infect Dis 19(3):488–492
Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M (2015) European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS 2016 27(5):333–48. https://doi.org/10.1177/0956462415618837. Epub 2015 Nov 24
Lautenschlager S (2015) Non-gonococcal infectious urethritis: pathogen spectrum and management. Hautarzt 66(1):12–18
Meyer T (2016) Diagnostic procedures to detect Chlamydia trachomatis infections. Microorganisms 4:e25
Meyer T, Brockmeyer NH (2017) Implementation of lymphogranuloma venereum identification in Chlamydia trachomatis testing by nucleic acid amplification tests. Clin Microbiol 6:274
Sandoz KM, Rockey DD (2010) Antibiotic resistance in Chlamydiae. Future Microbiol 5:1427–1442
Trei JS, Canas LC, Gould PL (2008) Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Transm Dis 35(9):827–833
www.cdc.gov/std/tg2015/chlamydia.htm. Last accessed 25 May 2019
Mycoplasma Genitalium
Bjartling C, Osser S, Persson K (2010) The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 117(3):361–364
CDC (2015) Sexually transmitted diseases treatment guidelines. Available from: https://www.cdc.gov/std/tg2015/emerging.htm. Last accessed 19 May 2019
Cunningham SA, Mandrekar JN, Rosenblatt JN, Patel R (2013) Rapid PCR detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. Int J Bacteriol 2103:168742
Dumke R, Thürmer A, Jacobs E (2016) Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany. Diagn Microbiol Infect Dis 86(2):221–223
European guideline on Mycoplasma genitalium infections (2016). Available from: https://www.iusti.org/regions/Europe/pdf/2016/IUSTI_mycoplasma_guidelines2016.pdf. Last accessed 19 May 2019
Férandon C, Peuchant O, Janis C et al (2011) Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture. Clin Microbiol Infect 17:155–159
Gaydos CA (2017) Mycoplasma genitalium: accurate diagnosis is necessary for adequate treatment. J Infect Dis 216(Suppl_2):S406–S411
Horner P, Ingle SM, Garrett F et al (2018) Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis. Sex Transm Infect 94(1):14–20
Jensen JS, Cusini M, Gomberg M, Moi H (2016) European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 30(10):1650–1656. https://doi.org/10.1111/jdv.13849. Epub 2016 Aug 9.
Lis R, Rowhani-Rahbar A, Manhart LE (2015) Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 61(3):418–426
Sonnenberg P, Ison CA, Clifton S et al (2015) Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of sexual attitudes and lifestyles (Natsal-3). Int J Epidemiol 44(6):1982–1994
Tabrizi SN, Su J, Bradshaw CS et al (2017) Prospective evaluation of ResistancePlus MG, a new multiplex quantitative PCR assay for detection of Mycoplasma genitalium and macrolide resistance. J Clin Microbiol 55(6):1915–1919
Tiplica GS, Radcliffe K, Evans C et al (2015) 2015 European guidelines for the management of partners of persons with sexually transmitted infections. JEADV 29:1251–1257
Touati A, Peuchant O, Jensen JS et al (2014) Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol 52(5):1549–1555
Unemo M, Jensen JS (2017) Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol 14(3):139–152
Vancutsem E, Soetens O, Breugelmans M et al (2011) A modified real-time PCR for detecting, differentiating, and quantifying Ureaplasma urealyticum and Ureaplasma parvum. J Mol Diagn 13:206–212
Walker J, Fairley CK, Bradshaw CS et al (2011) The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 11:35
Walker J, Fairley CK, Bradshaw CS Tabrizi SN, Chen MY, Twin J, Taylor N, Donovan B, Kaldor JK, McNamee K, Urban E, Walker S, Currie M, Birden H, Bowden F, Gunn J, Pirotta M, Gurrin L, Harindra V, Garland S, Hocking JS (2011) The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women. BMC Infect Dis 11: 35. https://doi.org/10.1186/1471-2334-11-35.
Wold C, Sorthe J, Hartgill U et al (2015) Identification of macrolide-resistant Mycoplasma genitalium using real-time PCR. J Eur Acad Dermatol Venereol 29(8):1616–1620
Trichomonas Vaginalis
www.cdc.gov/std/tg2015/trichomoniasis.htm. Last accessed 25 May 2019
First Describer
Credé CSF (1881) Die Verhütung der Augenentzündung der Neugeborenen. Arch Gynakol 17:50–53
Curtis AH (1930) A cause of adhesion in the right upper quadrant. JAMA 94:1221–1222
Fitz-Hugh T Jr (1934) Acute gonococcic peritonitis of the right upper quadrant in women. JAMA 102:2094–2096
Halberstaedter L, von Prowazek S (1907) Über Zelleinschlüsse parasitärer Natur beim Trachom. Arbeiten aus dem Kaiserlichen Gesundheitsamte 26:44–47
Neisser A (1879) Ueber eine der Gonorrhoe eigentümliche Micrococcusform. Centralbl Med Wissensch 28:497–500
Tully JG, Taylor-Robinson D, Cole RM, Rose DL (1981) A newly discovered mycoplasma in the human urogenital tract. Lancet 1(8233):1288–1291
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Buder, S., Lautenschlager, S. (2020). Gonorrhea and Urethritis. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58713-3_18-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-58713-3_18-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58713-3
Online ISBN: 978-3-662-58713-3
eBook Packages: Springer Reference MedicineReference Module Medicine